Popular
Understanding the Mechanisms Behind Resistant Hypertension
Heart MattersUnderstanding the Mechanisms Behind Resistant Hypertension
Steve Jackson, PharmD
Jan Basile, MD
Michael J. Bloch, MD, FAHA, FASH, FNLA, FSVM, FACP
How Delayed Colorectal Cancer Screening Impacts Quality of Life
Clinician's RoundtableHow Delayed Colorectal Cancer Screening Impacts Quality of Life
Christopher Cann, MD
The Clinical Consequences of Delayed Colorectal Cancer Screening
Clinician's RoundtableThe Clinical Consequences of Delayed Colorectal Cancer Screening
Peter Buch, MD, FACG, AGAF, FACP
Christopher Cann, MD
Understanding Residual Cardiovascular Risk in CKD and T2D
Diabetes DiscourseUnderstanding Residual Cardiovascular Risk in CKD and T2D
John W. Ostrominski, MD, MPH
Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
CME/CEChairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
Kathleen N. Moore, MD, MS
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
MinuteCE®ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Programs
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CEMaking the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Addressing Cost-Related Medication Non-Adherence in Diabetes
Diabetes DiscourseAddressing Cost-Related Medication Non-Adherence in Diabetes
Kimberly Narain, MD, MPH, PhD
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
MinuteCE®SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Living RheumSpot the Difference: Acute vs. Subacute Cutaneous Lupus
Avery H. LaChance, MD, MPH, FAAD
Key Advances in Rheumatology at CCR East 2026
Living RheumKey Advances in Rheumatology at CCR East 2026
Louis Bessette MD, FRCP(C), MSc
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Clinical Practice
Shared Decision-Making in Colorectal Cancer Screening
Clinician's RoundtableShared Decision-Making in Colorectal Cancer Screening
Gates B. Colbert, MD
Sarina Schrager, MD
Lashika Yogendran, MD
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
CME/CERethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Mukul Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD, MSc, FRCPC
Early Arthritis Insights from the CATCH Cohort
Living RheumEarly Arthritis Insights from the CATCH Cohort
Louis Bessette MD, FRCP(C), MSc
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
MinuteCE®Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Improving Migraine Diagnosis in Vulnerable Populations
NeuroFrontiersImproving Migraine Diagnosis in Vulnerable Populations
Juliana VanderPluym, MD
Healthy Aging and Nutrition: A Lifelong Approach
NutritionEdgeHealthy Aging and Nutrition: A Lifelong Approach
Shelina Ramnarine, PhD
AnnAlisa Behling, ND
Doctors Lounge
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
The Convergence“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
Brian P. McDonough, MD, FAAFP
Kate Rouch
Rehumanizing Healthcare with AI: Turning Data Into Meaningful Outcomes
MAPSChatsRehumanizing Healthcare with AI: Turning Data Into Meaningful Outcomes
Matt Birnholz, MD
Dr. Susanna Gallani
Inside Medical Affairs: MSL Insights on AI, Strategy, and Impact
MAPSChatsInside Medical Affairs: MSL Insights on AI, Strategy, and Impact
Matt Birnholz, MD
Brandon Young, PhD
Disparities in Acne Prescribing Patterns Highlight Structural and Racial Gaps
Clinician's RoundtableDisparities in Acne Prescribing Patterns Highlight Structural and Racial Gaps
"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
The Convergence"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
Brian P. McDonough, MD, FAAFP
Raja-Elie E. Abdulnour, MD
CME
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
MinuteCE®Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Jennifer Johnson, MD, PhD
Sjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
CME/CESjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
Chadwick R. Johr, MD
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE Virtual EventPrecision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
MinuteCE®Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Adam J. Luginbuhl, MD
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
CME/CE Broadcast ReplayEmerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD
Andrew G. Lee, MD
Valerie Biousse, MD
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
CME/CERedefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD
Kristi Orbaugh, MSN, RNP, AOCN
Industry Feature
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
Depression from Case to Clinic: Rethinking Partial Response with a Different Approach
Medical Industry FeatureDepression from Case to Clinic: Rethinking Partial Response with a Different Approach
Ashley Baker, MSN, PMHNP
Kimberly Giberga, MSN, APRN, FNP-C, PMHNP-BC
Bradford Perkins, MD
Improving Preterm Birth Outcomes with Virtual Cervix Technology
Medical Industry FeatureImproving Preterm Birth Outcomes with Virtual Cervix Technology
Mirella Mourad, M.D.
Integrating Patient Perspectives in Dermatologic Care
DermConsultIntegrating Patient Perspectives in Dermatologic Care
Mona Shahriari MD, FAAD
Linda Stein Gold, MD
Jennifer Soung, MD
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD
Is It Time to Rethink How We Support Depression Management?
Medical Industry FeatureIs It Time to Rethink How We Support Depression Management?
Charles Turck, PharmD, BCPS, BCCCP
Andrew J. Cutler, MD
Gustavo Alva, MD, DFAPA